Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?

Treatment doses of heparins are not recommended for acute ischemic stroke. Despite this, their use in this setting is widespread. We investigated whether subgroups of patients with acute ischemic stroke and atrial fibrillation, identified by clinical, hemostatic (d-dimer, prothombin fragments(1+2) [...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2006-02, Vol.37 (2), p.452-455
Hauptverfasser:	O'DONNELL, Martin J, BERGE, Eivind, SANDSET, Per Morten
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anticoagulants - therapeutic use Atrial Fibrillation - drug therapy Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system C-Reactive Protein - biosynthesis Cardiac dysrhythmias Cardiology. Vascular system Double-Blind Method Female Fibrin - biosynthesis Fibrin Fibrinogen Degradation Products - biosynthesis Heart Heparin, Low-Molecular-Weight - therapeutic use Humans Ischemia - drug therapy Ischemia - pathology Male Medical sciences Middle Aged Multivariate Analysis Neurology Odds Ratio Pharmacology. Drug treatments Placebos Prothrombin - biosynthesis Stroke - drug therapy Time Factors Treatment Outcome Vascular diseases and vascular malformations of the nervous system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!